Lund OsteoArthritis Division - From molecule to clinical implementation
1 – 10 of 108
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
The role of metabolic syndrome in osteoarthritis development : Is obesity the key driver?
- Contribution to journal › Article
-
Mark
Baseline pain medication is associated with longer duration of high adherence in a three-month digital treatment program for hip and knee osteoarthritis
- Contribution to journal › Article
-
Mark
Changes in health-related quality of life : a longitudinal registry study among over 15,000 participants of a digital education and exercise therapy for knee and hip osteoarthritis using EQ-5D-5L
- Contribution to journal › Article
-
Mark
Clinical care patterns in the 10-years prior to primary total hip replacement : a matched population-based case-control analysis in England
- Contribution to journal › Article
-
Mark
Sleep measurement and clinical impact in osteoarthritis and inflammatory arthritis : a scoping review
- Contribution to journal › Article
-
Mark
Utilization of medications for neuropathic pain in patients with and without knee and hip osteoarthritis in Sweden : A population-based cohort study
- Contribution to journal › Article
-
Mark
Association of hypertension and diabetes with opioid initiation and progression to long-term use after osteoarthritis diagnosis : A population-based register cohort study in Sweden
- Contribution to journal › Article
-
Mark
Metformin and incident osteoarthritis : Causal insights from a co-twin control study
(2026) In Osteoarthritis and Cartilage
- Contribution to journal › Article
-
Mark
Metformin use and the risk of incident osteoarthritis among individuals with diabetes : a register-based nested case-control study
- Contribution to journal › Article
- 2025
-
Mark
Osteoarthritis year in review 2025 : Epidemiology and therapy
- Contribution to journal › Article
